Edwards Lifesciences Corporation (EW)

Edwards Lifesciences Stock Forecast

Stock Price Forecast

According to 20 professional analysts, the 12-month price target for Edwards Lifesciences stock ranges from a low of $60 to a high of $95. The average analyst price target of $85.2 forecasts a 10.18% increase in the stock price over the next year.

Price Target: $85.20 (+10.18%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$60	$85.2	$89	$95
Change	-22.41%	+10.18%	+15.09%	+22.85%

Analyst Ratings

The average analyst rating for Edwards Lifesciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Mar '25	Apr '25	May '25	Jun '25	Jul '25	Aug '25
Strong Buy	6	5	5	5	5	5
Buy	4	5	5	5	6	6
Hold	10	9	9	9	9	8
Sell	1	1	1	1	1	1
Strong Sell	0	0	0	0	0	0
Total	21	20	20	20	21	20

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Larry Biegelsen Wells Fargo	Wells Fargo	Buy Maintains $84 → $88	Buy	Maintains	$84 → $88	+13.80%	Aug 7, 2025
Robbie Marcus JP Morgan	JP Morgan	Hold Maintains $80 → $85	Hold	Maintains	$80 → $85	+9.92%	Jul 25, 2025
William Plovanic Canaccord Genuity	Canaccord Genuity	Hold Maintains $75 → $81	Hold	Maintains	$75 → $81	+4.75%	Jul 25, 2025
Anthony Petrone Mizuho	Mizuho	Buy Maintains $87 → $95	Buy	Maintains	$87 → $95	+22.85%	Jul 25, 2025
Richard Newitter Truist Securities	Truist Securities	Hold Maintains $81 → $82	Hold	Maintains	$81 → $82	+6.04%	Jul 25, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

6.15B

Increased by 12.97%

from 5.44B

Revenue Next Year

6.74B

Increased by 9.65%

from 6.15B

EPS This Year

2.56

Decreased by -63.31%

from 6.97

EPS Next Year

2.85

Increased by 11.53%

from 2.56

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	4.39B	5.23B	4.46B	5.01B	5.44B	6.15B	6.74B	7.42B
Revenue Growth	0.88%	19.29%	-14.69%	12.23%	8.57%	12.97%	9.65%	10.15%
EPS	1.30	2.38	2.44	2.30	6.97	2.56	2.85	3.18
EPS Growth	-20.73%	83.08%	2.40%	-5.44%	202.39%	-63.31%	11.53%	11.71%
Forward PE	-	-	-	-	-	30.25	27.12	24.28
No. Analysts	-	-	-	-	-	37	37	25

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	6.3B	7.1B	7.9B
Avg	6.1B	6.7B	7.4B
Low	5.7B	6.2B	6.7B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	16.6%	15.2%	16.9%
Avg	13.0%	9.7%	10.2%
Low	4.6%	0.1%	-0.9%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	2.93	3.22	3.45
Avg	2.56	2.85	3.18
Low	2.38	2.56	2.70

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-58.0%	26.1%	21.1%
Avg	-63.3%	11.5%	11.7%
Low	-65.8%	0.1%	-5.5%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.